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Measles virus (MV) causes various responses including the induction of immune responses, transient immunosuppression and establishment of
long-lasting immunity. To obtain a comprehensive view of the effects of MV infection on target cells, DNA microarray analyses of two different
cell-types were performed. An epithelial (293SLAM; a 293 cell line stably expressing SLAM) and lymphoid (COBL-a) cell line were inoculated
with purified wild-type MV. Microarray analyses revealed significant differences in the regulation of cellular gene expression between these two
different cells. In 293SLAM cells, upregulation of genes involved in the antiviral response was rapidly induced; in the later stages of infection, this
was followed by regulation of many genes across a broad range of functional categories. On the other hand, in COBL-a cells, only a limited set of
gene expression profiles was modulated after MV infection. Since it was reported that V protein of MV inhibited the IFN signaling pathway, we
performed a microarray analysis using V knockout MV to evaluate V protein's effect on cellular gene expression. The V knockout MV displayed a
similar profile to that of parental MV. In particular, in COBL-a cells infected with the virus, no alteration of cellular gene expression, including
IFN signaling, was observed. Furthermore, IFN signaling analyzed in vitro was completely suppressed by MV infection in the COBL-a cells.
These results reveal that MV induces different cellular responses in a cell-type specific manner. Microarray analyses will provide us useful
information about potential mechanisms of MV pathogenesis.
© 2008 Elsevier Inc. All rights reserved.Keywords: Measles virus; Microarray; V protein; IFN signaling; Lymphoid cells; Epithelial cellsIntroduction
During measles virus (MV) infection, the virus first enters the
host via the respiratory route and replicates in tracheal and
bronchial epithelial cells. The virus then enters and replicates in
local lymphatic tissues and spreads through the blood to infect a
variety of organs. After a latent period lasting between 10 and
14 days, patients develop symptoms, such as fever, coryza,
coughing, and conjunctivitis, followed by the appearance of a
characteristic rash. Immune responses have been noted to occur
at almost the same time the rash fades. Recovery is accompanied
by life-long immunity to reinfection. Immunosuppression,
including marked lymphopenia, coincides with the appearance⁎ Corresponding author. Fax: +81 3 5449 5379.
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doi:10.1016/j.virol.2008.02.015of immune activation and lasts for several weeks after apparent
recovery (Griffin, 2001). The various pathogenic forms of
measles and the different immune responses are a result of the
interaction between the host and the virus. There are many in
vitro studies on the mechanisms that trigger these reactions in
MV-infected cells. For example, MV infection induces innate
immune and antiviral proteins, including interferon (IFN)
production in MV-infected epithelial, endothelial, and glial
cells (Dhib-Jalbut and Cowan, 1993; Helin et al., 2001; Noe
et al., 1999; Schneider-Schaulies et al., 1993; Vidalain et al.,
2002; Yokota et al., 2004). On the other hand, some reports have
demonstrated contrary results suggesting that MV does not
induce the production of IFN in peripheral blood mononuclear
cells (PBMC) (Naniche et al., 2000). Furthermore, recent reports
have indicated that a non-structural accessory protein, the V
protein, encoded within the phosphoprotein (P) gene, possesses
Fig. 1. Comparison of the replication of MV-HL in 293SLAM and COBL-a
cells. After infection at an MOI of 0.001, the viral titer was determined by
TCID50 at the indicated time points. The average of two independent mea-
surements is shown.
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Takeuchi et al., 2003; Yokota et al., 2003). However, there are
discrepancies between the various studies and the full picture
remains unclear.
High-density DNA microarrays can provide a powerful
approach to the profiling of the simultaneous expression of
thousands of genes. Previously, Bolt et al. performed DNA
microarray analysis with a limited number of human genes,
approximately 3000 genes, to monitor any change in the host
transcriptional profile of human PBMCs after infection with
MV, and found only a few genes to be upregulated by MV
infection (Bolt et al., 2002). To obtain a more comprehensive
view of the overall effects of MV infection in target cells, we
performed DNA microarray analysis containing more than
22,000 human genes of two different cell-types. Experiments
were designed to assess gene expression patterns in human
epithelial and lymphoid cells, which are the cell-types that are
targeted during the pathogenesis of primary MV infection. A
significant difference between these cells was observed. More
recently, Zilliox et al. reported a microarray analysis of MV-
infected dendritic cells and identified numerous genes that were
regulated by MV (622 upregulated and 931 downregulated
genes) (Zilliox et al., 2006). The profile of altered gene
expression in dendritic cells was similar to that in epithelial
cells in our results. Interestingly, cell-type specific modulation of
the IFN signaling pathway was identified in the present study. In
addition, to evaluate the effect of V protein on the modulation of
host gene expression, we generated V knockout MV by
employing a reverse genetics system and performed microarray
analysis. The present study provides an additional comprehen-
sive view of MV effects on different cells.
Results
Preparation of cells and virus
Experiments were designed to assess patterns of gene
expression in human epithelial and lymphoid cells, which are
the cell-types that are targeted during the pathogenesis of
primary MV infection. First, we established a human epithelial
cell line that was sensitive to wild-type MV infection. We took
293 human embryonic kidney epithelial-like cells and trans-
fected them with the signaling lymphocytic activation molecule
(SLAM) gene, a receptor for wild-type MV (Tatsuo et al.,
2001). The cells were highly susceptible to MV infection and
showed a large syncytium post infection (data not shown).
These cells were designated 293SLAM cells. To compare
transcriptional response between different cell-types after MV
infection, we used a novel established human lymphoid cell
line, COBL-a, which was established from a cultured umbilical
cord blood cell colony (Kobune et al., 2007). COBL-a cells are
a T cell lineage cell line expressing CD4 (helper-T), CD38
(immature T), CD46, and CD150 (SLAM). Cells are highly
sensitive to MV infection and cause CPE post infection. In
addition, a wild-type MV isolated from a blood specimen using
the COBL-a cells maintained pathogenicity specific for typical
acute measles against cynomolgus monkeys. The COBL-a cellsare therefore ideal for virus propagation and subsequent micro-
array assays.
We used the HL strain (Kobune et al., 1996) as a wild-type
MV. MV-HL was isolated from blood leukocytes of a patient
with typical measles and induced the typical clinical signs of
measles, including rashes, Koplik's spots, and transient marked
leukopenia in cynomolgus and squirrel monkeys. Thus, MV-HL
is considered to possess the pathogenicity of acute measles. The
HL strain grew well, both in COBL-a cells and 293SLAM cells,
reaching a similar maximum titer in both cells (Fig. 1). Since
MV-HL is propagated on B95a cells, a marmoset B-cell line
transformed with Epstein–Barr virus (EBV) (Kobune et al.,
1990), it was passaged twice in 293SLAM cells that were
insensitive to EBV to eliminate EBV in the MV stock solution.
The obtained virus solution was inoculated onto COBL-a cells
and, after 3 days, no EBV contamination was confirmed by RT-
PCR using EBV specific primer pairs (Teng et al., 1996) (data
not shown). To obtain the necessary quantity of MV, it was
propagated largely in COBL-a cells and was then purified by
ultracentrifugation.
Overview of expression microarray analysis
COBL-a cells and 293SLAM cells were inoculated with
purified MV at a multiplicity of infection (MOI) of 2 to ensure
that every cell was in contact with infectious viral particles.
Mock and infected cells were harvested at 6, 12, and 24 h post
infection and isolated poly(A+) RNAs were labeled with
Cyanine 3-dUTP or Cyanine 5-dUTP. The labeled samples were
hybridized on microarrays representing 22,272 human genes.
Hybridization signals were processed into expression ratios as
log 2 values (designated mean log ratios; see Materials and
methods). The genes with mean log ratios over 1 or under −1 in
at least one sample were extracted, and cluster analysis was
carried out. Data from all the arrays used in this paper are
available at DDBJ via CIBEX (http://www.cibex.nig.ac.jp/
cibex/HTML/index.html) under accession number CBX32.
Interestingly, significant differences in the regulation of cellular
gene expression were observed between 293SLAM and COBL-
a cells (Fig. 2). The number of genes that were up- and
downregulated with a mean log ratio over 1 or under −1 in
individual samples is shown in Fig. 2B. In 293SLAM cells,
Table 1
Classes of genes upregulated at 24 h post MV infection in 293SLAM cells
Functional classification Number
Antivirus 60
Metabolism 31
Transcription factor, transcription regulation 30
Zinc finger protein 24
Protein kinases and phosphatases 21
Channels and transporters 18
Nucleus and nuclear matrix 16
Histocompatibility and cell surface markers 15
Oncogenesis 13
Cytoskeleton and cell structure, motor protein 13
Protein degradation 9
Apoptosis, antiapoptosis 9
Cellular development and differentiation, physiology 8
Growth factor 8
RNA processing and binding modification 8
Cell adhesion and intercellular junction, extracellular matrix 7
Cell cycle related 7
Stress response/cell defense 6
Receptor and receptor-associated 6
tRNA 6
DNA modification and replication 5
Vesicular protein trafficking and fusion, vesicular formation 5
Immunity 4
Intracellular transporter 4
Signaling 3
Hormone related 3
Homeostasis 3
Protein modification 1
Translation 1
Unknown function 49
Hypothetical protein 308
Total 701
Fig. 2. Gene expression profiles of 293SLAM cells and COBL-a cells inoculated
with MV-HL. (A) Genes exhibiting the mean log ratio in all 6 samples were
extracted (19,415 genes). These genes were further extracted with |mean log
ratio|≥1, and the resulting 1,368 genes were assembled in the order obtained
from the results of hierarchical clustering analysis. The y-axis of the dendrogram
depicts Euclid square distance as the dissimilarity coefficient. The color bar on
the left side of the figure shows expression ratio against mock-infected RNA in
log2; red and blue indicate increase and decrease of mean log ratios, respectively.
(B) Kinetics of changes in total gene expression after MV infection. Individual
values for genes upregulated and genes downregulated by MV infection were
represented graphically.
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the number of regulated genes increased over time. On the other
hand, COBL-a cells showed little alteration in gene expression
despite similar viral replication rates as those observed in
293SLAM cells.Effects of MV on gene expression in 293SLAM cells
In 293SLAM cells, a series of cellular genes was found to be
upregulated and downregulated by virus infection. Among
genes that were altered early (6 h post infection), the most
apparent characteristic was the upregulation of a series of genes
that are related to innate immune and antiviral responses. This
result clearly showed typical early events after virus infection,
such as activation of IRF-3 and NF-kB, which result in the
induction of type I IFN. Furthermore, a series of IFN signal
transductions was subsequently observed. In particular, the
three principal families of IFN-inducible genes (RNA-activated
protein kinase [PKR], the 2′5′-oligoadenylate synthetases
[OAS], and the Mx proteins) were markedly induced. In
addition, activation of a broad range of functional responses that
are involved in the host antiviral response, including many IFN-
stimulated genes (ISG), inflammatory cytokines, and immune
pathways, was demonstrated. These results show that MV
infection and replication trigger a rapid and strong innate
antiviral response in 293SLAM cells. The number of upregu-
lated genes was slightly increased 12 h post infection (Fig. 2B).
At 24 h post infection, the number of upregulated genes
increased significantly; 701 upregulated genes were identified.
To facilitate the analysis of our data, we grouped the regulated
genes according to biological functions (Table 1). Upregulation
Table 2
Classes of genes downregulated at 24 h post MV infection in 293SLAM cells
Functional class Number
Metabolism 108
Protein degradation 35
Cytoskeleton and cell structure, motor protein 27
Ribosomal proteins 26
Protein modification 21
Cellular development and differentiation, physiology 20
Cell adhesion and intercellular junction, extracellular matrix 19
Nucleus and nuclear matrix 19
Transcription factor, transcription regulation 16
Receptor and receptor-associated 14
Protein kinases and phosphatases 11
Channels and transporters 11
Signaling 11
Stress response/cell defense 11
RNA processing and binding, modification 11
Immunity 8
Histocompatibility and cell surface markers 7
Cell cycle related 7
Vesicular protein trafficking and fusion, vesicular formation 7
Intracellular transporter 7
Homeostasis 7
Antivirus 5
Oncogenesis 5
Apoptosis, antiapoptosis 5
Zinc finger protein 3
Growth factor 3
Translation 3
Hormone related 1
DNA modification and replication 1
Unknown function 60
Hypothetical protein 152
Total 641 Table 3
Upregulated at 24 h post MV infection in COBL-a cells
Gene name cDNA
accession no.
Fold increase
(log2)
Dehydrogenase/reductase (SDR family)
member 2 (DHRS2), mRNA
NM_005794 2.2301
Rhabdoid tumor deletion region gene 1
(RTDR1), mRNA
NM_014433 1.8515
PRO1768 protein (PRO1768), mRNA NM_014099 1.6207
Ras protein-specific guanine nucleotide-
releasing factor 1 (RASGRF1)
NM_002891 1.5769
KIAA0590 gene product (KIAA0590), mRNA NM_014714 1.4823
cDNA FLJ30514 fis, clone BRAWH2000682 AK055076 1.4243
Titin (TTN), transcript variant novex-3 NM_133379 1.404
Crystallin, beta A1 (CRYBA1), mRNA NM_005208 1.3464
cDNA FLJ37863 fis, clone BRSSN2015907 AK095182 1.2957
cDNA FLJ30520 fis, clone BRAWH2000866 AK055082 1.2934
LOC135666 (LOC135666), mRNA XM_069484 1.2514
cDNA FLJ fis, clone PLACE6000414 AK122657 1.1769
cDNA FLJ31592 fis, clone NT2RI2002447 AK056154 1.141
cDNA FLJ35408 fis, clone SKNSH2008969 AK092727 1.139
Hypothetical gene supported by AF007152 XM_032158 1.1382
cDNA FLJ13701 fis, clone PLACE2000223 AK023763 1.1294
cDNA FLJ10500 fis, clone NT2RP2000369 AK001362 1.1278
Similar to IGE-BINDING PROTEIN
(LOC120889), mRNA
XM_062339 1.1235
cDNA FLJ35884 fis, clone TESTI2008960 AK093203 1.0978
Similar to cellular retinaldehyde-bindin XM_069035 1.081
cDNA FLJ fis, clone BRACE2032329 AK124476 1.0558
Transient receptor potential cation channel,
subfamily V, member 4 (TRPV4)
NM_021625 1.0507
Small inducible cytokine A4 (SCYA4), mRNA NM_002984 1.0031
324 H. Sato et al. / Virology 375 (2008) 321–330of a series of antiviral genes observed at 6 h post infection
persisted until 24 h post infection. Many genes that are
implicated in broad biological functions were upregulated, in
particular, cellular signal transducers, such as transcription
factors, zinc finger proteins, protein kinases, and phosphatases,
were induced. This result suggests that, during the late stages of
MV infection, MV replication strongly induces the expression
of many genes that control multiple cellular functions. About
half of the upregulated genes were classified as hypothetical or
unidentified genes.
The number of downregulated gene in 293SLAM cells was
also greatly increased 24 h post infection (Fig. 2B). A total of 641
geneswere identified.Many of the downregulated genes could be
classified in restricted categories (Table 2). Themajority of genes
that were downregulated were so-called ‘housekeeping genes’. In
particular, a large quantity of mitochondrial protein genes,
including those involved in the electron transport system and
energy metabolism, were downregulated. Furthermore, most
ribosomal proteins, including mitochondrial ribosomal proteins,
were downregulated. In addition, many genes implicated in the
cytoskeleton, cell structure and enzymes of the glycolytic path-
way and lipid metabolism were also downregulated. These
observations suggest that, during later stages of infection,
MV infection induced deficient maintenance of overall cellular
function.MV infection induced a biphasic modulation of gene ex-
pression in 293SLAMcells; in the early stage, a series of antiviral
gene expressions were rapidly induced, and during the later
stages of infection, MV replication modulated the expression of
genes across a broad range of functional categories.
Effects of MV on gene expression in COBL-a cells
In COBL-a cells, only limited sets of gene expression profiles
were modulated after MV infection. In fact, 24 h post infection,
only 23 genes were upregulated (Table 3). In contrast to that seen
in 293SLAM cells, the series of genes involved in innate
antiviral responses was not altered, other than a single cytokine.
This result in COBL-a cells suggests that MV suppresses
expression of genes involved in the host antivirus system and the
IFN-α/β signaling pathway. Only 17 genes were downregulated
in COBL-a cells 24 h post infection (Table 4). Many of these
genes were related to metabolic enzymes involved in sterol and
fatty acid. All of these genes were also downregulated in
293SLAM cells. This suggests that the downregulation signal of
MV infection was partially and weakly conserved between
293SLAM and COBL-a cells.
Effect of recombinant MV lacking V protein on gene expression
As with other paramyxoviruses, MV produces two non-
structural accessory molecules, the C and V proteins, encoded
within the phosphoprotein gene. In MV, several reports have
325H. Sato et al. / Virology 375 (2008) 321–330shown that the V protein possesses IFN-antagonist activity. To
evaluate the involvement of V protein in host gene expression
during MV infection, we established a reverse genetics system
for MV-HL (Yoneda et al., unpublished data). Using the
infectious clone, we succeeded in generating recombinant MV
lacking V protein expression. We performed a microarray
analysis using the V knockout MV. As shown in Fig. 3A, V
knockout MV-infected cells had a similar expression profile to
that of parental MV. In 293SLAM cells, rapid induction of
innate immune and antiviral responses was observed, similar to
that seen during parental MV infection. At 24 h post infection, V
knockout MV displayed slightly weak modulation of host gene
expression, but the categories of regulated genes highly
overlapped with that of parental MV. Interestingly, in COBL-a
cells, no alteration of cellular gene expression, including IFN
signaling, was observed with V knockout MV.
To confirm the early steps of IFN signaling during MV-HL
and V knockout MV infection, we examined tyrosine phos-
phorylation of signal transducer and activator 1 (STAT1) which
is induced by IFN response. COBL-a cells and 293SLAM cells
were infected with MV-HL or V knockout MV, and the cell
lysates were subjected to western blotting. As shown in Fig. 3B,
similar levels of tyrosine-phosphorylated STAT1 (pY-STAT1)
were detected in 293SLAM cells infected with both MV-HL and
V knockout MV. On the other hand, pY-STAT1 was not
detectably induced in COBL-a cells after MV-HL and V
knockout MV infection. Protein levels of STAT1 did not show
significant differences between uninfected and infected cells of
COBL-a and 293SLAM.Fig. 3. Effect of recombinant MV lacking V protein on gene expression.
(A) Comparison of the expression profiles between parental MVand V knockout
MV. 293SLAM and COBL-a cells were inoculated with MV-HL or V knockout
MV. Genes exhibiting the mean log ratio in all 10 samples were extracted (11,829
genes). These genes were further extracted with |mean log ratio|≥1, and the
resulting 1,012 genes were assembled in the order obtained from the results of
hierarchical clustering analysis. The y-axis of the dendrogram depicts Euclid
square distance as the dissimilarity coefficient. The color bar on the left side of the
figure shows the expression ratio against mock-infectedRNA in log2; red and blue
indicate increase and decrease of mean log ratios, respectively. (B) STAT1
activating tyrosine phosphorylation was tested by western blotting with STAT1
phosphopeptide-specific antibody in COBL-a cells and 293SLAM cells infected
with mock, MV-HL or V knockout MV. Total STAT1 level, GAPDH and MV-N
protein expression were analyzed in parallel.
Table 4
Downregulated genes at 24 h post MV infection in COBL-a cells
Gene name cDNA
accession no.
Fold increase
(log2)
Stearoyl-CoA desaturase (delta-9-desaturase)
(SCD)
NM_005063 −1.4765
Sterol-C4-methyl oxidase-like (SC4MOL) NM_006745 −1.3768
Fatty acid desaturase 2 (FADS2) NM_004265 −1.3506
Epidermal growth factor receptor pathway
substrate 8 (EPS8)
NM_004447 −1.2887
Midline 1 (Opitz/BBB syndrome) (MID1),
transcript variant 1
NM_000381 −1.1804
Isopentenyl-diphosphate delta isomerase (IDI1) NM_004508 −1.1777
7-dehydrocholesterol reductase (DHCR7) NM_001360 −1.165
Hypothetical protein FLJ11700 (FLJ11700) NM_024892 −1.1487
Insulin induced gene 1 (INSIG1) NM_005542 −1.1149
Acetyl-coenzyme A acetyltransferase 2
(acetoacetyl coenzyme A thiolase)
NM_005891 −1.113
Lipase A, lysosomal acid, cholesterol esterase
(Wolman disease) (LIPA)
NM_000235 −1.083
24-dehydrocholesterol reductase (DHCR24) NM_014762 −1.0687
Cytochrome P450, 51 (lanosterol 14-alpha-
demethylase) (CYP51)
NM_000786 −1.0677
LIM and cysteine-rich domains 1 (LMCD1) NM_014583 −1.047
Sialyltransferase 1 (beta-galactoside alpha-2,
6-sialytransferase) (SIAT1)
NM_003032 −1.0333
cDNA FLJ36451 fis, clone THYMU2013757 AK093770 −1.0286
3-hydroxy-3-methylglutaryl-coenzyme A
synthase 1 (soluble)
NM_002130 −1.0104Given these data, there is little difference in host gene
expression between MV-HL and V knockout MV, and V protein
is considered to have little effect on changing cellular gene
expression, in particular the series of genes responsible for IFN,
during virus replication.
MV suppresses the IFN signaling pathway in COBL-a cells but
not in 293SLAM cells
As assessed by microarray analysis, the modulation of host
gene expression profile induced by MV infection was different
in epithelial versus lymphoid cells. In particular, in the early
period of infection, it appeared that the antiviral responses,
including the expression of genes responsible for IFN, were not
326 H. Sato et al. / Virology 375 (2008) 321–330induced in COBL-a cells. To confirm whether the IFN signaling
pathway functions normally in COBL-a cells, we analyzed
changes in gene expression that occurred in response to IFN
treatment. 293SLAM cells and COBL-a cells were treated with
IFN-α for 24 h, and microarray analysis was performed. The
number of upregulated genes with a mean log ratio greater than 1
included 65 genes in COBL-a cells and 49 genes in 293SLAM
cells; the gene expression profiles, including the upregulation of
IFN-stimulated genes, was similar in these two cell lines. This
result indicates that the essential IFN signaling pathway in
COBL-a cells was functioning normally. Taken together with
profiles after MV infection, it appears that MV infection
suppressed this pathway in COBL-a cells but not 293SLAM
cells. Therefore, we examined the effects of V protein expression
and MV infection on IFN signaling in these two cell-types using
a luciferase reporter gene which was under the control of the
interferon signaling response element (ISRE). Treatment with
IFN-α increased luciferase activity by about 5.6- and 4.0-fold in
mock-infected 293SLAM and COBL-a cells, respectively,
compared to untreated controls (Fig. 4). In both 293SLAM
and COBL-a cells plasmid-expressed V protein completely
abolished IFN-α induced activation of the ISRE (Fig. 4). On the
other hand, in MV-infected 293SLAM cells, IFN-α-induced
reporter activity was further increased and reached a 10.9-fold
increase compared to untreated controls (Fig. 4), suggesting that
MV-induced synergistic ISRE activation. In contrast, MV
infection induced very little IFN signaling in COBL-a cells
(Fig. 4), which was consistent with microarray analysis results.
Interestingly, additional treatment with IFN-α did not induce
synergistic activation but rather suppressed the activity of the
IFN signaling pathway; there was only a 1.6-fold increase in
activity in COBL-a cells compared to untreated controls (Fig. 4).
These results indicate that MV infection in COBL-a cells
strongly suppresses the activity of the IFN signaling pathway.Fig. 4. MV infection inhibits IFN-α/β signaling in COBL-a but not 293SLAM
cells. (A) 293SLAM cells and (B) COBL-a cells were cotransfected with an
ISRE-luciferase (firefly) reporter gene, a control renilla luciferase gene, with or
without V-expression plasmid. After 42 h, cells were infected with mock or MV-
HL at an MOI of 2 for 6 h, and then treated with 1000 U of IFN-α per ml for
24 h. Relative expression levels were normalized by renilla luciferase activity,
and the activation increase is reported as fold activation.Discussion
We analyzed the expression of approximately 22,000 human
genes during MV infection in an epithelial (293SLAM cells)
and lymphoid (COBL-a cells) cell line using DNA microarrays,
and identified different profiles.
In 293SLAM cells, MV infection induced rapid and strong
host innate immune and antiviral responses. Host innate immune
responses are the first line of defense against infections.
Previously, various groups have reported that MV infection
induces innate immune responses, such as: activation of NF-κB
and IRF-3 transcription factors (Helin et al., 2001; Servant et al.,
2001); IFN biosynthesis (Helin et al., 2001; Naniche et al., 2000);
production of several cytokines (interleukin[IL]-6,-8, RANTES)
(Helin et al., 2001; Sato et al., 2005); activation of IFN-stimulated
gene factor 3 and GAF signaling complexes (Helin et al., 2001);
induction of IRF-1 and -7 (tenOever et al., 2002; Yokota et al.,
2004); and induction of immediate-early genes and genes linked
to antiviral responses (Bolt et al., 2002; Helin et al., 2002). In
addition to in vitro experiments, we have also studied the
pathogenicity of MV-HL in cynomolgus monkeys, and found
that type I IFN and several cytokines were transiently detected in
the serum after inoculation (Sato et al., 2008). In the present
study, microarray analysis clearly showed that MV infection
induced innate immune and antiviral responses in 293SLAM
cells, indicating that our microarray analysis was generally in
agreement with previous reports. Recently, Zillox et al. reported
that MV-infected dendritic cells also induced activation of
antiviral responses and downregulation of housekeeping genes
(Zilliox et al., 2006), coincident with our present study. A notable
difference was that no induction of PKR was observed in
dendritic cells (Zilliox et al., 2006) whereas, in our study,
293SLAM cells displayed clear upregulation of PKR after MV
infection. This difference may be due to the cell-type.
In addition to antiviral responses, the later stage of infection
showed comprehensive upregulation and downregulation of
host gene expression in 293SLAM cells (Fig. 2). Previous
microarray analysis reports stated that during various virus
infection and replication, the genes induced by antiviral
responses, such as those that are involved in the activation of
NF-κB (O'Donnell et al., 2006; Tian et al., 2002) and IRF-3
(Fredericksen et al., 2004; Grandvaux et al., 2002a), were only
part of the overall virus-induced gene expression profile that
occurred. In addition, our data indicate that type I IFN-induced
upregulation of only 49 genes in 293SLAM cells. Thus, it is
likely that most of the modulated gene expression that occurs
during the later stage of MV infection in 293SLAM cells is due
to cellular responses to MV as a result of the accumulation of
viral replication products and/or an increase in CPEs. Indeed,
we used UV-inactivated MV and showed that there was no
alteration of gene expression in 293SLAM cells 6 h and 24 h
post inoculation (data not shown). Therefore, alteration in gene
expression could not be triggered simply through signaling at
the cell surface, but requires virus replication and/or accumula-
tion of viral components in the cell. The activating signals that
control expression of MV-inducible genes require further
investigation.
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cells (Fig. 1), gene expression, including the expression of IFN-
inducible genes, was affected very little by MV infection in
COBL-a cells (Fig. 2). This result is in agreement with a
previous study showing that wild-type MV had the capacity to
suppress the induction of IFN-α˜/β in PBMCs (Naniche et al.,
2000). In contrast to our microarray analysis of COBL-a cell,
Bolt et al. reported that wt-MV-infected PBMCs upregulated
IFN-β and IRF-7 (Bolt et al., 2002). The MV solution Bolt used
contained EBV because the MV was propagated in an EBV-
transformed cells. EBV probably affected the gene expression,
because cytomegalovirus in the same family as EBV upregu-
lates many cytokine gene expressions (Zhu et al., 1998). Indeed,
we performed a preliminary microarray experiment using B95a-
passaged MV-HL and found that several factors, including IFN-
β and IRF-7, were upregulated (data not shown).
After MV infection, COBL-a cells induced low but apparent
IFN levels (data not shown); however, the series of genes
involved in innate antiviral responses was not upregulated
(Table 3). Usually, low levels of IFN production can induce
amplification of IFN production by a cellular autocrine
mechanism via IFN signal transduction (Grandvaux et al.,
2002b). However, in MV-infected COBL-a cells, amplification
of IFN secretion was not observed. In addition, the IFN reporter
assay showed that IFN-α treatment induced IFN signal
transduction effectively although MV infection strongly sup-
pressed transduction in COBL-a cells (Fig. 4). These results
indicate that, in COBL-a cells, the essential IFN production
capability and the IFN signaling pathway function normally, but
MV infection abrogates IFN signal transduction.
It has previously been reported that the V protein of MV is
involved in the inhibition of IFN signaling processes by
inhibition of IFN-induced STAT nuclear translocation (Palosaari
et al., 2003), the inhibition of STAT1 andSTAT2 phosphorylation
(Takeuchi et al., 2003), and the suppression of Jak phosphoryla-
tion (Yokota et al., 2003).We also confirmed that the V protein of
MV-HL, expressed by a mammalian expression plasmid,
completely suppresses IFN signaling in both 293SLAM and
COBL-a cells (Fig. 4). However, as shown in Fig. 3A, in COBL-a
cells, V knockout MV caused little change in cellular gene
expression, including IFN signaling. The V knockout MV grew
as well as the parental MV-HL (data not shown). Given these
data, during virus replication, V protein appeared to have little
effect on alteration of cellular gene expression, in particular the
series of IFN responsible genes. Thus, in COBL-a cells, other
factor(s) might also act as IFN-antagonist. In contrast, in MV-
infected 293SLAM cells, IFN signaling was not blocked by MV
infection (Fig. 4). Thus, V protein does not act as an IFN-
antagonist or inadequately suppresses the IFN signaling pathway
in MV-infected 293SLAM cells. These results indicate that
plasmid-expressed V protein can interfere with IFN signal
transduction in various cells including 293SLAM cells, but that
during MV infection, other factors may counteract and/or
overcome the inhibitory effect of V protein, depending on the
specific cell-type. The mechanism of cell-type specific inhibition
will need to be identified in order to clarify the function of the
viral proteins during MV replication.In addition to host antivirus responses, a number of changes
in gene expression observed in 293SLAM cells 24 h post
infection were not detected in COBL-a cells. Interestingly, in
vitro MV-induced immunosuppression is cell-type dependent.
The proliferation rates of lymphoid cells, such as peripheral
blood leucocytes, human T-cells, B cells, and monocytic cell
lines, were significantly reduced by MV infection. On the other
hand, no such effects were observed in cells of nonlymphoid
origin (Schlender et al., 1996). In addition, a recent study found
that IFN-γ-mediated antivirus activity against MV is caused in
epithelial, endothelial, and astroglial cells, but not in lymphoid
and neuronal cell lines (Obojes et al., 2005). These data imply
that cellular factors specific for lymphoid cells are implicated in
specific responses observed during MV infection and replica-
tion. In the present paper, we focused on the analysis of IFN
signal transduction suppression. In future, modification of other
pathways should be analyzed in detail.
This microarray analysis will help uncover new clues for
analyzing the behaviour of host genes in response to infection,
and the role of viral proteins in the context of MV infection.
Materials and methods
Cell culture
B95a cells and COBL-a cells were grown in RPMI1640
medium with 100 U penicillin per ml, 100 μg streptomycin per
ml, and 5% (B95a cells) or 10% (COBL-a cells) fetal calf serum
(FCS), at 37 °C in a 5% CO2 incubator. Human embryonic
kidney 293 cells and their derivatives were grown in Dulbecco
minimal essential medium with 10% FCS, penicillin, and
streptomycin at 37 °C in a 5% CO2 incubator.
Establishment of 293SLAM cells
In order to establish epithelial cell lines stably expressing
SLAM, total RNAwas isolated from B95a cells using ISOGEN
(NipponGene) and reverse transcribed with SuperScript II
reverse transcriptase (Invitrogen) and random primer (9-mer),
according to the manufacturer's instructions. The cDNA of
SLAM was amplified with a specific primer pair flanking the
EcoRI site, and then introduced into the pCAGGS mammalian
expression vector (pCAG-SLAM) (Tokui et al., 1997). One µg
of pCAG-SLAM and 0.1 μg of pcDNA3.1 encoding the
neomycin resistance gene (Invitrogen) were cotransfected with
FuGENE6 transfection reagent (Roche) into 293 cells seeded on
a 10-cm dish, according to the manufacturer's instructions.
Cells were then cultured in the presence of 100 μg/ml of G418.
A clone expressing the highest level of SLAM (293SLAM
cells) was selected for use in the following experiments.
Virus growth
293SLAM cells and COBL-a cells (1×106 per six-well plate)
were infected with MV-HL at an MOI of 0.001 for 1 h. The
inoculum was removed, and the cells were washed once with
medium and then incubated in medium containing 5% FCS.
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harvested 12, 24 and 48 h later, and carried out the freezing–
thawing cycle three times. Infectivity was determined by TCID50
titration using the standard method. The experiment was
repeated two times.
Generation of V knockout MV
To create V protein knockout MV, a previously established
plasmid encoding the cDNA of the full-length genome of
wild-type HL strain of MV was used (Yoneda et al.,
unpublished data). Two nucleotide substitutions (antigenome
2491AAAAAGGG2498 to 2491AAGAAGG2498) were introduced
into the editing site in the P gene of the plasmid to ensure that no
editing would occur; the result was designated pMV-ΔV. The
recombinant V knockout MV-HL was generated from pMV-ΔV.
Briefly, 293 cells were placed in a 6-well culture dish, inoculated
with a recombinant vaccinia virus (MVA-T7) for 1 h, and then
transfectedwith 1μg of pMV-ΔV, 1μg of pKSN1, 1μg of pKSP,
and 0.3 μg of pGEML per well, which expressed N, P, and L
proteins, respectively, under the control of a T7 promoter, using
FuGENE6. After incubation for 3 days, the cells were co-
cultivated with B95a cells at a concentration of 2×106 cells per
well, and further incubated until extensive cytopathic effects
were noted. To confirm the absence of V-expression, total RNA
was reverse transcribed with oligo-dT primer, and cDNA of the
P gene fragment containing the editing site (antigenome position
2401–3342) was amplified by PCR. No G residue insertion in
the editing site was identified by direct sequencing (data not
shown).
Preparation and purification of MVs
To eliminate EBV in the stock solution of MV-HL and
recombinant V knockout MV, which had been passaged on
B95a cells, primary virus solution was passaged twice in
293SLAM cells. The MV solution was inoculated into COBL-a
cells cultured in a Cell Factory (Nunc) and propagated. After
3 days, the cells and culture medium were harvested, subjected
to three cycles of freeze–thawing, and then centrifuged at
1,500 ×g for 10 min. The prepared virus solution was
centrifuged in a type19 fixed angle rotor (Beckman Inc.) at
19,000 rpm for 120 min at 4 °C. Pelleted virions were
resuspended in 5 ml of RPMI1640.
Preparation of RNA samples for microarray analysis
COBL-a cells and 293SLAM cells (3×107) were infected
with MV-HL or V knockout MV at an MOI of 2. After 1 h of
adsorption at 37 °C, the inocula were replaced with warm
spent medium. Alternatively, both cells were treated with
1,000 IU/ml of human universal type I IFN (PBL Biomedical
Laboratories). At the predetermined time after addition of
the virus or IFN, the medium was removed and the cells were
lysed with an ISOGEN reagent. Total RNA was prepared from
the lysate in accordance with the manufacturer's instructions.
Poly(A)+RNAwas prepared from total RNAwith a MicroPoly(A)Purist Kit (Ambion), in accordance with the manufacturer's
instructions.
Microarray preparation and expression profile acquisition
DNA microarray analysis was performed as previously
described (Ito et al., 2003; Kobayashi et al., 2004; Miura et al.,
2006; Sakamoto et al., 2005; Yanagisawa et al., 2006). A set of
synthetic polynucleotides (80-mers) that represented 22,272
human transcripts mostly originating from the RefSeq clones
deposited in the NCBI database was purchased (MicroDiag-
nostic, Japan) and arrayed on a slide glass (coated slide glass for
the microarray, type I; Matsunami, Kishiwada, Japan) with a
custom-made arrayer (designated the 22K array) (Ito et al.,
2003; Kobayashi et al., 2004). Poly(A)+RNA (2 μg) was
labeled with SuperScript II and Cyanine 5-dUTP or Cyanine 3-
dUTP (PerkinElmer). A pair of the Cyanine 5- and Cyanine 3-
labeled samples was hybridized onto a single microarray. All
pairs of target and control samples were labeled and hybridized
to microarrays along with color flip of Cyanine 5 and Cyanine
3. Labeling, hybridization, and subsequent washes of micro-
arrays were performed with a Labeling & Hybridization Kit
(MicroDiagnostic), in accordance with the manufacturer's
instructions. Hybridization signals were measured with a
GenePix 4000A scanner (Axon Instruments, CA, USA) and
then processed into primary expression ratios ([Cyanine 5-
intensity obtained from each target or control sample]/[Cyanine
3-intensity obtained from each control or target sample], which
are indicated as ‘median of ratios’ in GenePix Pro 3.0 software
(Axon Instruments)). Normalization was performed for the
median of ratios (primary expression ratios) by multiplying
normalization factors calculated for each feature on a micro-
array by the GenePix Pro 3.0 software (designated normalized
ratios). After conversion of the normalized ratios into log2
values (designated log ratios), log ratios derived from pairs of
Cyanine 3-labeled target and Cyanine 5-labeled control samples
were converted into reciprocals. Eventually, log ratios derived
from pairs of Cyanine 5-labeled target and Cyanine 3-labeled
control samples and the reciprocal log ratios derived from pairs
of Cyanine 3-labeled target and Cyanine 5-labeled control
samples were subjected to calculation of mean averages for
individual genes (designated mean log ratios). Data processing
and subsequent hierarchical clustering analysis were performed
with an MDI gene expression analysis software package
(MicroDiagnostic). Genes exhibiting the mean log ratio in all
data sets were extracted. These genes were further extracted
with mean log ratio greater than 1 or lower than −1, and the
resulting genes were assembled in the order obtained from the
results of hierarchical clustering analysis. All the data in
accordance with the MIAME guideline were deposited at DDBJ
via CIBEX (http://www.cibex.nig.ac.jp/cibex/HTML/index.
html) under accession numbers CBX32.
Western blotting
293SLAM cells and COBL-a cells in 3.5 cm-diameter dish
were infected with MV-HL or V knockout MVat an MOI of 2.
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the SDS sample buffer, and then subjected to a 30-s sonication
with a Sonifier 450 (BRANSON). Cell lysate was boiled for
5 min, and then resolved on 10% SDS-PAGE gels and
transferred to polyvinylidene difluoride membranes (Millipore).
The membranes were incubated with a 1:1000 dilution of anti-
STAT1 rabbit polyclonal antibody (Santa Cruz Biotechnology),
a 1:200 dilution of anti-pY-STAT rabbit polyclonal antibody
(Santa Cruz Biotechnology), a 1:1000 dilution of anti-N rabbit
polyclonal antibody, or a 1:1000 dilution of anti-GAPDHmouse
monoclonal antibody (CHEMICON) at 4 °C overnight. The
membranes were washed three times with PBS, then incubated
with a 1:2000 dilution of horseradish peroxidase-conjugated
rabbit anti-mouse, or goat anti-rabbit, IgG (Dako) at room
temperature for 1 h. Proteins that bound antibodies were detected
by ECL Plus western blotting detection reagents (Amersham).
Luciferase reporter assays
To construct expression plasmids encoding the MV-V gene,
the P gene of MV-HL was amplified with specific primer pairs
containing the EcoRI sequence flanking its 5' terminus and
inserted into the EcoRI site of the pCAGGS eukaryotic
expression vector, and then introduced specific insertion of G
residues at the editing site by a PCR-based mutagenesis
technique using the QuikChange site-directed mutagenesis kit
(Stratagene) (pCAG-V). 293SLAM cells were seeded at 2×105
cells per well of a 24-well tissue culture plate and then
transiently cotransfected with 0.1 μg of pISRE-Luc, 10 ng of
pRL-CMV (Promega) with or without 1.2 μg of pCAG-V using
FuGENE6. COBL-a cells were seeded at 4×105 cells per well
of a 24-well plate and transiently cotransfected with 1 μg of
pISRE-Luc, 20 ng of pRL-CMV, and with or without 2.4 μg of
pCAG-V using Lipofectamine2000 (Invitrogen) according to
the manufacturer's protocol. After 42 h, cells were infected with
mock or MV at an MOI of 2 for 6 h, and then treated with
1,000 IU/ml of human universal type I IFN and incubated for
24 h. Cells were lysed with passive lysis buffer (Promega), and
luciferase activity was measured using Dual-luciferase reporter
assay system (Promega). Experiments were performed in
triplicate.
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